Meetings

Lisbon, Portugal | June12-13, 2016 | Sixth Meeting

The Management Committee of the International Pharmaceutical Regulators Forum (IPRF) met in Lisbon, Portugal, June 12-13,  2016. It continued a strategy development process that had been initiated at the meeting in December 2015.

The work of IPRF has evolved since its establishment. With the regulatory environment changing in a dynamic manner IPRF is expected to develop, if it wants to continue to provide value for members and external stakeholders. Therefore, the Management Committee had initiated a strategy development process at the meeting in Jacksonville, and the final outcomes will be adopted at the Management Committee meeting in November 2016. At the Meeting in June, the Management Committee completed the strategy analysis and developed the future business model for the initiative.

> Sixth Meeting of the IPRF – Public Summary/Public Statement

Jacksonville, USA | 15 December 2015 | Fifth meeting

The Management Committee of the International Pharmaceutical Regulators Forum (IPRF) met in Jacksonville, Florida, US, on 7 and 8 December 2015. Within the two and a half years after its establishment, the initiative has achieved substantial progress. In order to define the future direction, the Management Committee embarked on a strategy development process, which should be completed in June 2016..

The IPRF provides to its members a unique opportunity to leverage the expert scientific knowledge, regulatory and operational experience and on-going technical harmonization work of other members. The work of IPRF has evolved since its establishment. With the regulatory environment changing in a dynamic manner IPRF is expected to develop, if it wants to continue to provide value for members and external stakeholders. Therefore, the Management Committee has decided to elaborate a strategy for the initiative for the next five years. The process was initiated at the meeting in Jacksonville, and will be concluded at the next meeting in June 2016. One of the objectives of the IPRF is to identify the need for regulatory harmonization/convergence, as well as for regulatory cooperation, including work-sharing, in specific areas.

> Fifth IPRF meeting in Jacksonville, USA – Public Summary/Public Statement

Fukuoka, Japan | 8-9 June, 2015 | Fourth meeting

The Management Committee of the International Pharmaceutical Regulators Forum (IPRF) met in Fukuoka on 8 and 9 June 2015.  It was the fourth meeting after its establishment in 2013.

The IPRF provides to its members a unique opportunity to leverage the expert scientific knowledge, regulatory and operational experience and on-going technical harmonization work of other members. The goals, scope, objectives, governance, collaborative mechanisms and communications are reflected in the Terms of Reference published on the IPRF website.

> Public Summary/Public Statement – 4th IPRF meeting

Lisbon, Portugal | 11 November 2014 | Third Meeting

The Management Committee of the International Pharmaceutical Regulators Forum (IPRF) met in Minneapolis, MN, US, on 2 and 3 June 2014. It was the second meeting of this group, following on the work from the first meeting in November 2013 in Osaka, Japan.

The IPRF provides to its members a unique opportunity to leverage the expert scientific knowledge, regulatory and operational experience and on-going technical harmonization work of other members. The goals, scope, objectives, governance, collaborative mechanisms and communications are reflected in the Terms of Reference (ToR) of the IPRF that were adopted at the first meeting in Osaka. The participants decided at the meeting to establish their group as the Management Committee of the IPRF. The ToR will be revised accordingly.

> 3rd_IPRF_Meeting_Public_Statement_Final.pdf

Minneapolis, US | 2-3 June 2014 | Second Meeting

The Management Committee of the International Pharmaceutical Regulators Forum (IPRF) met in Minneapolis, MN, US, on 2 and 3 June 2014. 

It was the second meeting of this group, following on the work from the first meeting in November 2013 in Osaka, Japan.

> Public Summary/Public Statement

Osaka, Japan, 11-12 November 2013 – First IPRF Meeting

The International Pharmaceutical Regulators Forum (IPRF) met in Osaka, Japan, on 11 and 12
November 2013, in connection with the ICH Steering Committee meeting.

It was the first full meeting of this group, after the decision of the Regulators Forum to reinforce its role – five
years after the initial meeting – as the IPRF. Representatives from eleven Regulatory
Authorities, from six Regional Harmonization initiatives (RHIs) and from WHO participated in
the meeting.

> Public Summary/Public Statement

La Hulpe, Belgium, 3-4 June 2013 – Regulators Forum Meeting

Five years after it met for the first time in June 2008, the Regulators Forum decided to reinforce its role on international cooperation activities between pharmaceutical regulators as the International Pharmaceutical Regulators Forum (IPRF).

The IPRF will provide members a unique opportunity to leverage the expert scientific knowledge, regulatory and operational experience, on-going technical harmonization work, and information access of other participating regulators.

The first goal is to enable all parties to identify new approaches and specific best practices, and develop smart strategies for dealing with the challenges of the globalization of the pharmaceutical industry.

The second goal is to provide a global overview of the different regulatory developments at national and international level and enable open sharing of information and ideas among regulatory leaders with hands-on operational responsibilities. This information sharing will allow the forum participants to discuss issues at an actionable level of detail.

The third goal is to support international regulatory cooperation in areas which are not covered by existing initiatives.

IPRF Public Meeting Report – La Hulpe, Belgium – 4 June 2013